Ganga Pharmaceuticals Limited (BOM:539680)
India flag India · Delayed Price · Currency is INR
12.00
0.00 (0.00%)
At close: Feb 12, 2026

Ganga Pharmaceuticals Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
28.2828.2826.3727.3625.8624.89
Revenue Growth
5.03%7.22%-3.60%5.78%3.91%4.83%
Gross Profit
15.2515.2514.1814.8513.3811.97
Operating Income
-0.17-0.17-1.630.08-0.51-0.13
Net Income
1.021.020.790.470.390.38
Earnings Per Share
0.170.170.120.070.100.09
EPS Growth
55.08%41.67%71.43%-27.67%7.53%80.00%

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
0.580.583.020.30.290.2
Total Debt
10.910.914.2113.5818.2619.28
Net Cash (Debt)
-10.32-10.32-11.19-13.28-17.97-19.07
Net Cash Growth
------
Net Cash Per Share
-1.73-1.73-1.69-2.01-4.43-4.70

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-13.11-13.11-5.77-12.64-0.4-2.11
Capital Expenditures
-0.37-0.37-0.99-0.22-0.15-0.15
Free Cash Flow
-13.48-13.48-6.76-12.86-0.55-2.25
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
53.91%53.91%53.78%54.29%51.73%48.10%
Operating Margin
-0.59%-0.59%-6.17%0.31%-1.99%-0.51%
Pretax Margin
4.57%4.57%3.59%2.31%2.05%2.06%
Profit Margin
3.59%3.59%3.00%1.70%1.52%1.52%
FCF Margin
-47.65%-47.65%-25.63%-47.02%-2.11%-9.06%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJul '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
70.5969.8962.24253.25143.94109.87
PS Ratio
2.512.511.874.322.191.67